Criteria | Number of Patients in | |
---|---|---|
Schizophrenia Cohort | Bipolar Disorder Cohort | |
Total number of patients with ≥1 inpatient admissions for treatment of condition of interest* during study period** and | 228 | 389 |
Received oral ziprasidone, ariprazole, or quetiapine on the day of discharge or immediately preceding one and | 90 | 169 |
≥6 months enrollment prior to “qualifying” admission and | 66 | 127 |
≥6 months enrollment subsequent to date of discharge of “qualifying” admission and | 52 | 110 |
Had no evidence of receipt of clozapine at any time during study period and | 47 | 109 |
Were not enrolled in insurance plan with mental health “carve out” and | 45 | 106 |
Were aged ≥18 years as of date of qualifying hospital admission and | 44 | 87 |
Had no evidence of epilepsy prior to qualifying admission and | 44 | 85 |
Had no evidence of other condition of interest* during study period | 43 | 84 |